Laura Fanucchi

We have new work out today @JAMAHealthForum exploring if removal of Medicaid prior auths for buprenorphine changed buprenorphine prescriptions Hypothesis: PAs are a barrier to care and removal will result in more prescriptions Results: There was minimal change after PA removal

Initiation of MOUD may improve readmissions in patient directed discharges @Dr_Robertson_MD @LauraFanucchi

Kudos @Dr_Robertson_MD 📢 initiating MOUD in the hospital for people with OUD is critical to improve outcomes @UKYMedicine

🌟🌟Amazing work @AnnaMariaSouth @LauraFanucchi Lofwall🌟🌟 We are proud of your continued commitment and support for the incarcerated population with Opioid Use Disorder. #UK_HealthCare @UKYMedicine @DarwinConwell @alicecthornton #advocacy #compassion uknow.uky.edu/uk-healthcare/…

Congratulations to my nontweeting colleague Dr South, Dr. Lofwall and ⁦@LauraFanucchi⁩ Treating Opioid Use Disorder in Patients Who Are Incarcerated: Quandaries of a Hospitalist | Substance Use and Addiction Medicine | JAMA | JAMA Network jamanetwork.com/journals/jama/…

via @NYTimes I hope it is available over OTC soon. nytimes.com/2023/02/15/hea…

We are delighted to announce that JSAT’s underlying name has been officially changed to Journal of Substance Use & Addiction Treatment. Thanks to all who supported this change. #wordsmatter #stigmakills sciencedirect.com/science/articl…

Catch us in action this weekend at the @NationalLeague Orlando E64 Showcase! Good luck to all clubs competing, especially our fellow @kingshammer teams. #EarnYourPlace 💪🏼⚽️

Here at #AMERSA2022 and just saw this incredible news from my home state - justice.gov/usao-edky/pr/u…

@DrEllenEaton Thanks @elleneaton @dsolsMD and team!

Note that this work was inspired by work by @LauraFanucchi who demonstrated that OPaT for PWID is associated w reduced LOS and improved addiction treatment outcomes. Laura has cont this imp study & we’re all looking forward 2 findings from her RO1

Fantastic work led by ⁦⁦@dsolsMD⁩ on OPAT eligibility 4 PWID. Clinicians who report PWID = not eligible for OPAT are more likely to cite (unfounded) picc safety, legal risks. They also report less social, case mgmt support. Great collab, 🤩 team! ⁦@IDWeek2022⁩

🚨 Imp Guidance on Injection-related Endocarditis. Especially helpful 4 #IDtwitter, clinicians, pharmacists who are working 2 develop evidence-based protocols. Highlights role of stigma, oral & LA antibiotics, & bup/methadone 👏🏻 👏🏻 @IDDoc1978 @LauraFanucchi

Management of Infective Endocarditis in People Who Inject Drugs: A Scientific Statement From the American Heart Association ahajournals.org/doi/abs/10.116… @MayoClinicGIM @MayoMN_IMRES @MayoPsych @IDSAInfo @ACCinTouch @ACPinternists @escardio @JWatch @STS_CTsurgery @ESCMID @ACEPNow 🧵

Yes! Thank you @honoraenglander @coreysdavis for this powerful call to action. Proud that @universityofky @UK_HealthCare we have addiction consult & @UKHospitalists all getting waivered! @dtweaverMD @DevinOller @romilchadha @PeterAkpunonu

Trying to get funding for research

Design and protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a randomi… pubmed.ncbi.nlm.nih.gov/35847566/ 🎯🎯🎯 Thank you for the heavy lifting Laura and colleagues. @MayoClinicINFD

📣NEW online! Design & protocol of the Buprenorphine plus Outpatient Parenteral Antimicrobial Therapy (B-OPAT) study: a RCT of integrated outpatient treatment of opioid use disorder & severe, injection-related infections @LauraFanucchi @universityofky ⬇ bit.ly/3IuMfUS

I’m telling you this time is going to be different

Schools scared to death. The truth is, one education under desks, Stooped low from bullets; That plunge when we ask Where our children Shall live & how & if